Advertisement

Topics

AAN: Isradipine Offers No Benefit in Parkinson Disease

08:00 EDT 10 May 2019 | Drugs.com

FRIDAY, May 10, 2019 -- Isradipine does not appear to slow progression of disability in patients with de novo Parkinson disease (PD), according to a study presented at the annual meeting of the American Academy of Neurology, held from May 4 to 10 in...

Original Article: AAN: Isradipine Offers No Benefit in Parkinson Disease

NEXT ARTICLE

More From BioPortfolio on "AAN: Isradipine Offers No Benefit in Parkinson Disease"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Neurology - Central Nervous System (CNS)
Alzheimer's Disease Anesthesia Anxiety Disorders Autism Bipolar Disorders Dementia Epilepsy Multiple Sclerosis (MS) Neurology Pain Parkinson's Disease Sleep Disorders Neurology is the branch of me...